Related Experiment Videos
Masseter muscle rigidity and nondepolarizing neuromuscular blocking agents
A Albrecht1, D J Wedel, G A Gronert
1Department of Anesthesiology, Mayo Clinic Rochester, MN 55905, USA.
Mayo Clinic Proceedings
|April 1, 1997
Summary
Masseter muscle rigidity, a potential indicator for malignant hyperthermia (MH), was observed in patients receiving non-depolarizing muscle relaxants. Further research is needed to confirm this association and its implications for anesthesia safety.
Area of Science:
- Anesthesiology
- Pharmacology
- Genetics
Background:
- Masseter muscle rigidity is a known risk factor for malignant hyperthermia (MH), typically associated with succinylcholine administration.
- Nondepolarizing muscle relaxants are generally considered safe for patients susceptible to MH.